Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis

Clearance of apoptotic neutrophils and resolution of inflammation

(2016) Mallary C. Greenlee-Wacker   IMMUNOLOGICAL REVIEWS

Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease

(2016) Sylwia Smolinska et al.   INFLAMMATORY BOWEL DISEASES

Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohnʼs Disease

(2016) Ji Li et al.   INFLAMMATORY BOWEL DISEASES

Management of Acute Severe Colitis in Children With Ulcerative Colitis in the Biologics Era

(2016) C. Romano et al.   PEDIATRICS

Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets

(2016) Vipul Yadav et al.   Translational Research

Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies

(2015) M. Fumery et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Management of ulcerative colitis

(2015) John M Fell et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Proinflammatory role of the histamine H4 receptor in dextrane sodium sulfate-induced acute colitis

(2015) Bastian Schirmer et al.   BIOCHEMICAL PHARMACOLOGY

Mast cells and inflammatory bowel disease

(2015) Guy Boeckxstaens   CURRENT OPINION IN PHARMACOLOGY

Immunoregulatory Pathways Involved in Inflammatory Bowel Disease

(2015) Gabriela Fonseca-Camarillo et al.   INFLAMMATORY BOWEL DISEASES

Immunopathogenesis of IBD: current state of the art

(2015) Heitor S. P. de Souza et al.   Nature Reviews Gastroenterology & Hepatology

Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease

(2015) Cristina-Sorina Cătană et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The therapeutic potential of histamine receptor ligands in inflammatory bowel disease

(2014) Detlef Neumann et al.   BIOCHEMICAL PHARMACOLOGY

Cutting Edge: Histamine Receptor H4 Activation Positively Regulates In Vivo IL-4 and IFN-  Production by Invariant NKT Cells

(2014) M. C. Leite-de-Moraes et al.   JOURNAL OF IMMUNOLOGY

Functional characterization of histamine H4 receptor on human mast cells

(2014) E. Angel Jemima et al.   MOLECULAR IMMUNOLOGY

Non-pulmonary allergic diseases and inflammatory bowel disease: A qualitative review

(2014) David S Kotlyar   WORLD JOURNAL OF GASTROENTEROLOGY

Histamine and gut mucosal immune regulation

(2013) S. Smolinska et al.   ALLERGY

The Role of Polymorphonuclear Leukocyte Trafficking in the Perpetuation of Inflammation During Inflammatory Bowel Disease

(2013) Jennifer C. Brazil et al.   INFLAMMATORY BOWEL DISEASES

Evaluation of Fecal Myeloperoxidase as a Biomarker of Disease Activity and Severity in Ulcerative Colitis

(2012) Ibrahim Masoodi et al.   DIGESTIVE DISEASES AND SCIENCES

The role of neutrophils during intestinal inflammation

(2012) B M Fournier et al.   Mucosal Immunology

Histamine H4 receptor activation enhances LPS-induced IL-6 production in mast cells via ERK and PI3K activation

(2011) Pragnya Desai et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active Inflammatory Bowel disease (IBD)

(2010) M. Raithel et al.   INFLAMMATION RESEARCH

Mast Cells in Allergic Asthma and Beyond

(2010) Sebastian Reuter et al.   YONSEI MEDICAL JOURNAL

In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties

(2009) MI Strakhova et al.   BRITISH JOURNAL OF PHARMACOLOGY

Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis

(2009) Ibrahim Masoodi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble-IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model

(2009) S. Matsumoto et al.   JOURNAL OF IMMUNOLOGY